Heart Beat August 2007 Issue

Heart Beat: 08/07

Centrally active ACE inhibitors such as captropil (Capoten) and fosinopril (Monopril), used to treat hypertension and congestive heart failure, are associated with slower rates of cognitive decline among the elderly compared to other blood pressure medications such as benazepril (Lotensin) and enalapril (Vasotec), according to research presented at the May conference of the American Geriatrics Society. Because centrally active ACE inhibitors cross the blood-brain barrier, the membrane that protects the brain from chemicals in the blood, it is thought that they help fight dementia by reducing inflammation in the brain and decreasing oxidative stress, which is cell death caused by free radicals in the body

To continue reading this article you must be a paid subscriber.

Subscribe to Heart Advisor

Get the next year of HEART ADVISOR for just $20. That's a savings of $19 off the regular rate.

With your paid subscription you will receive unlimited access to all of our online content. That is over a decade of previous issues from Cleveland Clinic, the hospital rated #1 in cardiac care by U.S. News & World Report - free of charge.

Subscriber Log In

Forgot your password? Click Here.

Already subscribe but haven't registered for all the benefits of the website? Click here.